In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?
This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.
MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson &amp; Johnson MedTech, and Medtronic.
***
Enjoy the show? Follow <a href="https://devicetalksweekly.castos.com/subscribe">DeviceTalks Weekly</a> on all major podcast players + Follow us on <a href="https://www.youtube.com/@DeviceTalks">YouTube.com/@DeviceTalks</a> to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at <a href="https://devicetalks.castos.com/subscribe">https://devicetalks.castos.com/subscribe</a>

<description>
 &lt;p&gt;In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?&lt;/p&gt;
&lt;p&gt;This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.&lt;/p&gt;
&lt;p&gt;MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson &amp;amp; Johnson MedTech, and Medtronic.&lt;/p&gt;
&lt;p&gt;***&lt;/p&gt;
&lt;p&gt;Enjoy the show? Follow &lt;a href="https://devicetalksweekly.castos.com/subscribe"&gt;DeviceTalks Weekly&lt;/a&gt; on all major podcast players + Follow us on &lt;a href="https://www.youtube.com/@DeviceTalks"&gt;YouTube.com/@DeviceTalks&lt;/a&gt; to ensure you never miss an episode.&lt;/p&gt;
&lt;p&gt;Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at &lt;a href="https://devicetalks.castos.com/subscribe"&gt;https://devicetalks.castos.com/subscribe&lt;/a&gt;&lt;/p&gt;
&lt;h3&gt;Chapters&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;(00:02:00) - Quick recap of DeviceTalks Minnesota&lt;/li&gt;&lt;li&gt;(00:07:05) - MassDevice’s Orthopedic Device Companies Special Report for 2026&lt;/li&gt;&lt;li&gt;(00:08:20) - Masimo shareholders give green light to $10B acquisition by Danaher&lt;/li&gt;&lt;li&gt;(00:09:56) - ResMed enters merger agreement to acquire Noctrix Health for $340 million&lt;/li&gt;&lt;li&gt;(00:14:03) - Johnson &amp; Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery study&lt;/li&gt;&lt;li&gt;(00:15:45) - Medtronic merges Cardiac Surgery, Aortic units into Cardiovascular Surgery business&lt;/li&gt;&lt;li&gt;(00:19:45) - FOMO Studio – Yossi Bar, CEO, LEM Surgical&lt;/li&gt;&lt;li&gt;(00:31:22) - Keynote Interview- Wayne Allen, CEO, Perfuze&lt;/li&gt;&lt;/ul&gt;
 </description>


                    In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?
This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.
MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson & Johnson MedTech, and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
                

DeviceTalks Podcast Network

Perfuze CEO lays out the challenge – and the promise – of building a new stroke aspiration device

Perfuze CEO lays out the challenge – and the promise – of building a new stroke aspiration device

Description